Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer.

About half of the patients treated with docetaxel in the setting of metastatic castration-resistant prostate cancer (CRPC) are non-responders. Therefore, a marker of response would be beneficial for clinical decision-making. We evaluated class III β-tubulin (βIII-tubulin) expression as a predictor o...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lucas Maahs, Bertha E Sanchez, Nilesh Gupta, Meredith Van Harn, Evelyn R Barrack, Prem-Veer Reddy, Clara Hwang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2019-01-01
coleção:	PLoS ONE
Acesso em linha:	https://doi.org/10.1371/journal.pone.0222510
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!